Interim data success for Salubris Biotherapeutics’ heart failure candidate
US company Salubris Biotherapeutics (SalubrisBio) has seen its heart failure therapy, JK07, achieve some success in interim results taken from…
US company Salubris Biotherapeutics (SalubrisBio) has seen its heart failure therapy, JK07, achieve some success in interim results taken from…